Proliferative Response of B Chronic Lymphocytic Leukemia Lymphocytes Stimulated with IL2 and Soluble CD23

References

• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. The French-American-British (FAB) Cooperative group. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J. Clin. Pathol. 1989; 42: 567–584
   PubMed Web of Science ®Google Scholar
• Delespesse G., Suter U., Mossalayi M. D., Bettler B., Sarfati M., Hofstetter H., Kilcherr E., Debré P., Dalloul A. H. Expression, structure and function of CD23 antigen. Adv. Immunol. 1991; 49: 149–221
   PubMed Web of Science ®Google Scholar
• Kawabe T., Maekawa N., Maeda Y., Hosoda M., Yodoi J. Induction of FcRII/CD23 on phytohemagglutinin-activated human peripheral blood T lymphocytes. I. Enhancement by IL-2 and IL-4. J. Immunol. 1991; 147: 548–553
   PubMed Web of Science ®Google Scholar
• Mossalayi M. D., Lecron J. C., Dalloul A. H., Sarfati M., Bertho J. M., Hofstetter H., Delespesse G., Debr S. P. Soluble CD23 (FceR11) and IL1 synergistically induce early human thymocyte maturation. J. Exp. Med. 1990; 171: 959–964
   PubMed Web of Science ®Google Scholar
• Mossalayi M. D., Arock M., Bertho J. M., Blanc C., Dalloul A. H., Hofstetter H., Sarfati M., Delespesse G., Debré P. Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23. Blood 1990; 75: 1924–1927
   PubMed Web of Science ®Google Scholar
• Liu Y. J., Cairns J. A., Holder M. J., Abbot S. D., Jansen K. U., Bonnefoy J. Y., Gordon J., MacLennan I. C. M. Recombinant 25-kDa CD23 and interleukin la promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur. J. Immunol. 1991; 21: 1107–1114
   PubMed Web of Science ®Google Scholar
• Morel F., Goube de Laforest P., Brizard A., Gombert J., Lecron J. C. Identification of the B cell derived T cell colony promoting activity to soluble CD23. Eur. Cytokine. Netw. 1992; 3: 485–494
   PubMedGoogle Scholar
• Liu Y. J., Mason D. Y., Johnson G. D., Abbot S., Gregory C. D., Hardie D. L., Gordon J., MacLennan I. C. M. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol. 1991; 21: 1905–1910
   PubMed Web of Science ®Google Scholar
• Sarfati M., Fournier S., Christoffersen M., Biron G. Expression of CD23 antigen and its regulation by IL4 in chronic lymphocytic leukemia. Leukemia Res. 1990; 14: 47–55
   PubMed Web of Science ®Google Scholar
• Sarfati M., Bron D., Lagneaux L., Fonteyn C., Frost H., Delespesse G. Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia. Blood 1988; 71: 94–98
   PubMed Web of Science ®Google Scholar
• Cairns J. A., Gordon J. Intact, 45-kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblasts. Eur. J. Immunol. 1990; 20: 539–543
   PubMed Web of Science ®Google Scholar
• Karray S., Vazquez A., Merle-Beral H., Olive D., Debré P., Galanaud P. Synergistic effect of recombinant IL2 and interferon-γ on the proliferation of human monoclonal lymphocytes. J. Immunol. 1987; 138: 3824–3828
   PubMed Web of Science ®Google Scholar
• Karray S., Merle-Beral H., Vazquez A., Gerard J. P., Debré P., Galanaud P. Functional heterogeneity of B-CLL lymphocytes: dissociated responsiveness to growth factors and distinct requirements for a first activation signal. Blood 1987; 70: 1105–1110
   PubMed Web of Science ®Google Scholar
• Karray S., Delfraissy J. F., Merle-Béral H., Wallon C., Debré P., Galanaud P. Positive effects of interferon-α on B cell-type chronic lymphocytic leukemia proliferative response. J. Immunol. 1988; 140: 774–778
   PubMed Web of Science ®Google Scholar
• Dadmarz R., Rabinowe S. N., Cannistra S. A., Andersen J. W., Freedman A. S., Nadler L. M. Association between clonogenic cell growth and clinical risk group in B-cell chronic lymphocytic leukemia. Blood 1990; 76: 142–149
   PubMed Web of Science ®Google Scholar
• Stephenson C. F., Desai Z. R., Bridges J. M. The proliferative activity of B-chronic lymphocytic leukaemia lymphocytes prior to and after stimulation with TPA and PHA. Leukemia Res. 1991; 15: 1005–1012
   PubMed Web of Science ®Google Scholar
• Digel W., Schmid M., Heil G., Conrad P., Gillis S., Porzsolt F. Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias. Blood 1991; 78: 753–759
   PubMed Web of Science ®Google Scholar
• Foa R., Tos A. G., Di Celle P. F., Carbone A., Marchis D., Vischia F., Cignetti A., Guarini A. Cytokines in B-cell chronic lymphocytic leukemia. Leukemia & Lymphoma 1991; Suppl.: 7–11
   Web of Science ®Google Scholar
• Morabito F., Prasthofer E. F., Dunlap N. E., Grossi C. E., Tilden A. B. Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1. Blood 1987; 70: 1750–1757
   PubMed Web of Science ®Google Scholar
• Foa R., Giovarelli M., Fierro M. T., Bonferroni M., Forni G. Autocrine or paracrine models of cytokine production and utilization in B-cell chronic lymphocytic leukemia. Nouv. Rev. Fr. Hematol. 1988; 30: 339–000
   PubMedGoogle Scholar
• Hahn T., Shulman L., Karov Y., Vorst E., Berrebi A. Involvement of interleukin-6 in the autocrine stimulation of chronic lymphocytic leukemia B cells by tumor necrosis factor. Leukemia & Lymphoma 1991; Suppl.: 65–69
   Web of Science ®Google Scholar
• Fournier S., Tran I. D., Suter U., Biron G., Delespesse G., Sarfati M. The in vivo expression of type B CD23 mRNA in B-chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: comparison with their normal cellular counterparts. Leukemia Res. 1991; 15: 609–618
   PubMed Web of Science ®Google Scholar
• Fournier S., Delespesse G., Rubio M., Biron G., Sarfati M. CD23 antigen regulation and signaling in chronic lymphocytic leukemia. J. Clin. Invest. 1992; 89: 1312–1321
   PubMed Web of Science ®Google Scholar
• Knuutila S., Elonen E., Teerenhovi L., Rossi L., Leskinen R., Bloomfield C. D., De La Chapelle A. Trisomy 12 in B cells of patients with B-cell chronic lymphocytic leukemia. N. Engl. J. Med. 1986; 314: 865–869
   PubMed Web of Science ®Google Scholar
• Autio K., Elonen E., Teerenhovi L., Knuutila S. Cytogenetic and immunologic characterization of mitotic cells in chronic lymphocytic leukaemia. Eur. J. Haematol. 1987; 39: 289–298
   PubMed Web of Science ®Google Scholar
• Brizard A., Brizard F., Dreyfus B., Morel F., Lecron J. C., Tanzer J., Preu d'Homme J. L. Chromosomal analysis of purified B-chronic lymphocytic leukemia lymphocyte cultures. Comparison with whole blood cultures and in situ hybridization. Leukemia & Lymphoma. 1993, in press.
   Google Scholar
• Binet J. L., Auquier A., Dighiero G., Chatang C., Piguet H., Goasguen J., Vaugier G., Potron G., Colona P., Oberling F., Thomas M., Tchernia G., Jacquillat A. T. C., Boivin P., Lesty C., Duault M. T., Monconduit M., Belabbes S., Gremy F. A new prognostic classification of chronic lymphocytic leukemia derived from a multivaried survival analysis. Cancer 1981; 48: 198–206
   PubMed Web of Science ®Google Scholar
• Rai K. R., Sawitsky A., Cronkite E. P., Channa A. D., Levy R. N., Pasternack B. S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
   PubMed Web of Science ®Google Scholar
• Pellegrino M. A., Ferrone S., Dierich M. P. Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulfhydril compound 2-amino-ethyl-isothio-uronium bromide. Clin. Immunol. Immunopathol. 1975; 3: 324–329
   PubMedGoogle Scholar
• Pezzella F., Tse A. G. D., Cordell J. L., Pulford K. A. F., Gatter K. C., Mason D. Y. Expression of the bcl-2 oncogene protein is not specific for the 14; 18 chromosomal translocation. Am. J. Pathol. 1990; 137: 225–232
   PubMed Web of Science ®Google Scholar
• Nunez G., Hockenbery D., McDonnell T. J., Sorensen C. M., Korsmeyer S. J. Bcl-2 maintains B cell memory. Nature 1991; 353: 71–73
   PubMed Web of Science ®Google Scholar
• Adachi M., Tefferi A., Greipp P. R., Kipps T. J., Tsujimoto Y. Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia. J. Exp. Med. 1990; 171: 559–564
   PubMed Web of Science ®Google Scholar
• Cordone I., Matutes E., Catovsky D. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity. Leukemia 1992; 6: 902–905
   PubMed Web of Science ®Google Scholar
• Buschle M., Campana D., Carding S. R., Richard C., Hoffbrand A. V., Brenner M. K. Interferon y inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J. Exp. Med. 1993; 177: 213–218
   PubMed Web of Science ®Google Scholar
• Dancescu M., Rubio-Trujillo M., Biron G., Bron D., Delespesse G., Sarfati M. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates bcl-2 expression. J. Exp. Med. 1992; 176: 1319–1326
   PubMed Web of Science ®Google Scholar
• Aubry J. P., Pochon S., Graber P., Jansen K. U., Bonnefoy J. Y. CD21 is a ligand for CD23 and regulates IgE production. Nature 1992; 358: 505–507
   PubMed Web of Science ®Google Scholar